Based on bioinformatic analysis, it was indicated that the S2 subunit of SARS-CoV-2 exhibits robust interactions with P53, breast cancer type 1 susceptibility protein (BRCA-1), and breast cancer type 2 susceptibility protein [133]. This evidence concerns the gene TP53 and breast carcinoma.